Christiano Robles Rodrigues Alves

Christiano Robles Rodrigues Alves

Auto-generated profile, based on publicly available information

Christiano Robles Rodrigues Alves

Center for Genomic Medicine, Massachusetts General Hospital, Boston, MA, USA

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
11 February 2019 in Nature Metabolism
Verified
Journal Article
Closed access
PDF file
HTHirokazu Takahashi
Hirokazu Takahashi
CAChristiano R. R. Alves
Christiano R. R. Alves
KSKristin I. Stanford
Kristin I. Stanford
RMRoeland J. W. Middelbeek
Roeland J. W. Middelbeek
PNPasquale Nigro
Pasquale Nigro
LGLaurie J. Goodyear
Laurie J. Goodyear

1 February 2014 in Perceptual and Motor Skills
Verified
Journal Article
Closed access
CAChristiano R. R. Alves
Christiano R. R. Alves
VTVictor H. Tessaro
Victor H. Tessaro
LTLuis A. C. Teixeira
Luis A. C. Teixeira
KMKarina Murakava
Karina Murakava
Hamilton RoschelHamilton Roschel
Hamilton Roschel
MTMonica Yuri Takito
Monica Yuri Takito
Acute moderate intensity continuous aerobic exercise can improve specific cognitive functions, such as short-term memory and selective attention. Moreover, high-intensity interval training (HIT) has been recently proposed as a time-efficient alternative to traditional cardiorespiratory exercise. However, considering previous speculations that the exercise intensity affects cognition in a U-shaped fashion, it was hypothesized that a HIT session may impair cognitive performance. Therefore, this study assessed the effects of an acute HIT session on selective attention and short-term memory tasks. 22 healthy middle-aged individuals ( M age = 53.7 yr.) engaged in both (1) a HIT session, 10 1 min. cycling bouts at the intensity corresponding to 80% of the reserve heart rate interspersed by 1 min. active pauses cycling at 60% of the reserve heart rate and (2) a control session, consisting of an active condition with low-intensity active stretching exercise. Before and after each experimental session, cognitive performance was assessed by the Victoria Version of the Stroop test (a selective attention test) and the Digit Span test (a short-term memory test). Following the HIT session, the time to complete the Stroop “Color word” test was significantly lower when compared with that of the control session. The performances in the other subtasks of the Stroop test as well as in the Digit Span test were not significantly different. A HIT session can improve cognitive function.

1 May 2014 in Experimental Gerontology
Verified
Journal Article
Closed access
BGBruno Gualano
Bruno Gualano
AMAndré Regis Macedo
André Regis Macedo
CAChristiano Robles Rodrigues Alves
Christiano Robles Rodrigues Alves
Hamilton RoschelHamilton Roschel
Hamilton Roschel
FBFabiana Benatti
Fabiana Benatti
RPRosa Maria L.N. Pereira
Rosa Maria L.N. Pereira

1 August 2012 in Journal of Sport and Exercise Psychology
Verified
Journal Article
Closed access
CAChristiano Robles Rodrigues Alves
Christiano Robles Rodrigues Alves
BGBruno Gualano
Bruno Gualano
PTPollyana Pereira Takao
Pollyana Pereira Takao
PAPaula Avakian
Paula Avakian
RFRafael Mistura Fernandes
Rafael Mistura Fernandes
MTMonica Yuri Takito
Monica Yuri Takito
The aim of this study was to compare the effects of acute aerobic and strength exercises on selected executive functions. A counterbalanced, crossover, randomized trial was performed. Forty-two healthy women were randomly submitted to three different conditions: (1) aerobic exercise, (2) strength exercise, and (3) control condition. Before and after each condition, executive functions were measured by the Stroop Test and the Trail Making Test. Following the aerobic and strength sessions, the time to complete the Stroop “non-color word” and “color word” condition was lower when compared with that of the control session. The performance in the Trail Making Test was unchanged. In conclusion, both acute aerobic and strength exercises improve the executive functions. Nevertheless, this positive effect seems to be task and executive function dependent.

3 October 2013 in PLOS ONE
Verified
Journal Article
Open access
PDF file
CAChristiano Robles Rodrigues Alves
Christiano Robles Rodrigues Alves
CFCarlos Alberto Abujabra Merege Filho
Carlos Alberto Abujabra Merege Filho
FBFabiana Benatti
Fabiana Benatti
SBSonia Maria Dozzi Brucki
Sonia Maria Dozzi Brucki
RPRosa Maria L.N. Pereira
Rosa Maria L.N. Pereira
BGBruno Gualano
Bruno Gualano
To assess the effects of creatine supplementation, associated or not with strength training, upon emotional and cognitive measures in older woman. This is a 24-week, parallel-group, double-blind, randomized, placebo-controlled trial. The individuals were randomly allocated into one of the following groups (n=14 each): 1) placebo, 2) creatine supplementation, 3) placebo associated with strength training or 4) creatine supplementation associated with strength training. According to their allocation, the participants were given creatine (4 x 5 g/d for 5 days followed by 5 g/d) or placebo (dextrose at the same dosage) and were strength trained or not. Cognitive function, assessed by a comprehensive battery of tests involving memory, selective attention, and inhibitory control, and emotional measures, assessed by the Geriatric Depression Scale, were evaluated at baseline, after 12 and 24 weeks of the intervention. Muscle strength and food intake were evaluated at baseline and after 24 weeks. After the 24-week intervention, both training groups (ingesting creatine supplementation and placebo) had significant reductions on the Geriatric Depression Scale scores when compared with the non-trained placebo group (p = 0.001 and p = 0.01, respectively) and the non-trained creatine group (p < 0.001 for both comparison). However, no significant differences were observed between the non-trained placebo and creatine (p = 0.60) groups, or between the trained placebo and creatine groups (p = 0.83). Both trained groups, irrespective of creatine supplementation, had better muscle strength performance than the non-trained groups. Neither strength training nor creatine supplementation altered any parameter of cognitive performance. Food intake remained unchanged. Creatine supplementation did not promote any significant change in cognitive function and emotional parameters in apparently healthy older individuals. In addition, strength training per se improved emotional state and muscle strength, but not cognition, with no additive effects of creatine supplementation. Clinicaltrials.gov NCT01164020

27 December 2019 in Neurology
Verified
Journal Article
Closed access
PDF file
CAChristiano R.R. Alves
Christiano R.R. Alves
RZRen Zhang
Ren Zhang
AJAlec J. Johnstone
Alec J. Johnstone
RGReid Garner
Reid Garner
PNPann H. Nwe
Pann H. Nwe
KSKathryn J. Swoboda
Kathryn J. Swoboda
Objective Identifying simple biomarkers that can predict or track disease progression in patients with spinal muscular atrophy (SMA) remains an unmet clinical need. To test the hypothesis that serum creatinine (Crn) could be a prognostic biomarker for monitoring progression of denervation in patients with SMA, we determined whether serum Crn concentration correlates with disease severity in patients with SMA. Methods We examined a cohort of 238 patients with SMA with 1,130 Crn observations between 2000 and 2016. Analyses were corrected for age, and 156 patients with SMA had dual-energy x-ray absorptiometry data available for correction for lean mass. We investigated the relationship between Crn and SMA type, survival motor neuron 2 (SMN2) copies, and Hammersmith Functional Motor Scale (HFMS) score as primary outcomes. In addition, we tested for associations between Crn and maximum ulnar compound muscle action potential amplitude (CMAP) and motor unit number estimation (MUNE). Results Patients with SMA type 3 had 2.2-fold (95% confidence interval [CI] 1.93–2.49; p < 0.0001) higher Crn levels compared to those with SMA type 1 and 1.7-fold (95% CI 1.52–1.82; p < 0.0001) higher Crn levels compared to patients with SMA type 2. Patients with SMA type 2 had 1.4-fold (95% CI 1.31–1.58; p < 0.0001) higher Crn levels than patients with SMA type 1. Patients with SMA with 4 SMN2 copies had 1.8-fold (95% CI 1.57–2.11; p < 0.0001) higher Crn levels compared to patients with SMA with 2 SMN2 copies and 1.4-fold (95% CI 1.24–1.58; p < 0.0001) higher Crn levels compared to patients with SMA with 3 SMN2 copies. Patients with SMA with 3 SMN2 copies had 1.4-fold (95% CI 1.21–1.56; p < 0.0001) higher Crn levels than patients with SMA with 2 SMN2 copies. Mixed-effect model revealed significant differences in Crn levels among walkers, sitters, and nonsitters (p < 0.0001) and positive associations between Crn and maximum CMAP (p < 0.0001) and between Crn and MUNE (p < 0.0001). After correction for lean mass, there were still significant associations between Crn and SMA type, SMN2 copies, HFMS, CMAP, and MUNE. Conclusions These findings indicate that decreased Crn levels reflect disease severity, suggesting that Crn is a candidate biomarker for SMA progression. We conclude that Crn measurements should be included in the routine analysis of all patients with SMA. In future studies, it will be important to determine whether Crn levels respond to molecular and gene therapies.